STTK:NASDAQShattuck Labs, Inc. Analysis

STTK trades at $4.93, just below its 20‑day SMA of $5.05 and comfortably above the 200‑day SMA of $4.13, while the 50‑day SMA sits at $6.21, indicating a neutral price stance. Technicals show a RSI of 45.5 (mid‑range) and a bullish MACD crossover (histogram +0.057), with volume trending upward, suggesting modest buying pressure. However, the stock carries a high beta of ~1.38 and a 30‑day volatility of >108%, underscoring pronounced price swings.
Fundamentally, the company is still pre‑revenue (≈$1 M) with negative gross (‑2.98%) and operating margins (‑52.6%), but it holds a strong cash position of $90.4 M against $2.9 M of debt, yielding a low leverage profile. Valuation multiples are extreme – a price‑to‑sales of ~470× and a price‑to‑book of 3.88× – yet the model projects a **201% upside** and analysts (6) assign a “strong_buy” consensus, bolstered by a recent $54.9 M warrant‑exercise capital infusion and a Citigroup “Buy” rating.